Advertisement

Topics

Janssen-Cilag Farmacéutica Company Profile

05:39 EDT 18th June 2018 | BioPortfolio

NIL

Location

Mendoza 1259
Buenos Aires
1428
Argentina

Contact

Phone: (011)4789-7270
Email: cds@janssen.com


News Articles [283 Associated News Articles listed on BioPortfolio]

Saliva-based diagnostics offer possibility to detect HPV-induced throat cancer

This follows the extension of a QUT collaboration with Johnson & Johnson Innovation, Janssen Vaccines & Prevention, and Janssen Cilag Pty Ltd.

Excelencia farmacéutica italiana en I+D durante el 33rd Congress of the European Association ...

     (Logo: https://mma.prnewswire.com/media/655337/Fidia_Farmceutici_Logo.jpg) Fidia Farmaceutici anunció hoy los resultados positivos de un ensayo en fase II en el que se evalúa la efica...

Nuevo Developer Portal Gateway API de Ambrosus para la cadena de suministro 2.0

Ambrosus - la solución líder del mundo de blockchain-IoT para asegurar la calidad en la industria alimentaria y farmacéutica - ha presentado su nuevo Developer Read more...

French Competition Body Fines Janssen €25m For Delaying Generic Durogesic

Janssen-Cilag has been fined €25m by the French competition authority for running a concerted campaign to prevent generic competition to...   

Pasta De Lassar Andromaco Skin Protectant 25 Percent Zinc Oxide by MarcasUSA: Recall - Potential Contamination

Audience: Consumer, Pediatrics ISSUE: MarcasUSA, LLC and Industria Farmacéutica Andromaco, S.A. de C.V. voluntarily recalled four lots of Pasta De Lassar Andromaco Skin Protectant, 25% zinc oxide to ...

Saliva test aims to detect HPV throat cancers

(Queensland University of Technology) A QUT researcher is developing a simple saliva test to detect Human papilloma virus (HPV) in throat cancers.This follows the extension of a QUT collaboration with...

France fines J&J 25 million Euro for blocking generics

A fine of Euros 25 million was imposed on Janssen-Cilag and its parent company Johnson & Johnson (J&J) by the French Competition Authority on 20 December 2017. This occurred in response to a r...

MorphoSys Announces Approvals for Tremfya(R) (Guselkumab) for the Treatment of Moderate-to-Severe Plaque Psoriasis in Brazil and Australia (news with additional features)

DGAP-News: MorphoSys AG / Key word(s): Regulatory Approval 05.04.2018 / 16:07 The issuer is solely responsible for the content of this announcement. Planegg/Munich, Germany, April 5, 2018 ...

Drugs and Medications [50 Associated Drugs and Medications listed on BioPortfolio]

Pasta de lassar andromaco [MarcasUSA LLC]

Drug Facts

Long last make up 02 (neo heliopan) [Janssen Cosmetics GmbH]

Drug Facts

Risperidone [WOCKHARDT USA LLC.]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Risperidone [WOCKHARDT LIMITED]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC).

Janssen Research & Development, LLC, part of the Janssen pharmaceutical companies of Johnson & Johnson, and NYU School of Medicine partnered to establish the Compassionate Use Advisory Committee (Comp...

Ingredientes Farmacéuticos Activos Potencialmente Inapropiados en Adultos Mayores: Lista IFAsPIAM: Panel de Consenso Argentino.

To perform a list agreed by Argentinean experts and adapted to the local context containing potentially inappropriate (PI) medications in old people (OP) usingthe Delphi consensus technique optimized ...

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

In recent years, the anti-CD38 monoclonal antibody daratumumab (Darzalex; Janssen-Cilag Pty Ltd) has been shown to be highly efficacious in relapsed and refractory multiple myeloma, with the final res...

Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.

The article Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets, written by Brendan Mulhern, Yan Feng, Koonal Shah, Mathieu F. Janssen, Michael Herdman, Ben van Hout, Nancy Devlin was originally...

Effects of phrase and word frequencies in noun phrase production.

There is mounting evidence that the ease of producing and understanding language depends not only on the frequencies of individual words but also on the frequencies of word combinations. However, in t...

Clinical Trials [21 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Efficacy and Safety of HX 575 vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

This is a double-blind, randomized, multicenter, parallel-group, equivalence study involving about 462 clinically stable hemodialysis patients aged 18 years or above suffering from anemia ...

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH & Co. KG to Boehringer Ingelheim compared to ambroxol ...

Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

This trial evaluated folic acid supplementation after oral administration of the ethinyl estradiol + levonorgestrel + folic acid (0.02 mg + 0.10 mg + 0.4 mg) coated tablet (Level-Fol® Bio...

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

This is a randomized, double-blind, multicenter clinical phase III study involving about 105 cancer patients aged >18 years who are receiving palliative chemotherapy and who are suffering ...

Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

This clinical trial evaluated the comparative bioavailability of two injectable suspension formulations of medroxyprogesterone acetate + estradiol cypionate, a test (Depomês®, 25 mg/mL m...

Companies [49 Associated Companies listed on BioPortfolio]

Janssen-Cilag Farmacéutica

NIL

Janssen-Cilag EMEA, EMHF, ESHA & ISG

Janssen-Cilag EMEA, a division of Janssen Pharmaceutica N.V., is a research-based pharmaceutical company that develops and markets innovative, high-quality pharmaceutical products and services aim...

Janssen-Cilag International NV

Janssen-Cilag AG

NIL

JANSSEN-ORTHO INC

Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products ...

More Information about "Janssen-Cilag Farmacéutica" on BioPortfolio

We have published hundreds of Janssen-Cilag Farmacéutica news stories on BioPortfolio along with dozens of Janssen-Cilag Farmacéutica Clinical Trials and PubMed Articles about Janssen-Cilag Farmacéutica for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Janssen-Cilag Farmacéutica Companies in our database. You can also find out about relevant Janssen-Cilag Farmacéutica Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record